![Alicia Craig-Rodriguez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alicia Craig-Rodriguez
Profile
Alicia Craig-Rodriguez served as the President of Comprehensive NeuroScience, Inc. from 2011 to 2012.
She received an undergraduate degree from the University of Central Florida and both an undergraduate degree and an MBA from the University of South Florida.
Former positions of Alicia Craig-Rodriguez
Companies | Position | End |
---|---|---|
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | President | 09/02/2012 |
Training of Alicia Craig-Rodriguez
University of South Florida | Masters Business Admin |
University of Central Florida | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | Commercial Services |
- Stock Market
- Insiders
- Alicia Craig-Rodriguez